Artelo Biosciences
ARTL
ARTL
16 hedge funds and large institutions have $1.57M invested in Artelo Biosciences in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$39.2K | |
| 2 | +$17.4K | |
| 3 | +$16.1K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$7.91K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.31K |
Top Sellers
| 1 | -$216K | |
| 2 | -$195K | |
| 3 | -$176K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$93.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$43K |